Polycystic Ovary Syndrome

Complex MONDO:0008487 Endocrine Disease Reproductive Disease

Ask OpenScientist

Ask a research question about Polycystic Ovary Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

4
Pathophys.
6
Phenotypes
4
Genes
6
Treatments
6
References
2
Deep Research
🏷

Classifications

Harrison's Chapter
ENDOCRINOLOGY_METABOLISM
⚙

Pathophysiology

4
Hyperandrogenism
Excess androgen production from ovarian theca cells and adrenal glands leads to hirsutism, acne, and alopecia. Elevated LH stimulates theca cell androgen production.
Androgen Biosynthesis link
Show evidence (4 references)
PMID:38152131 SUPPORT
"Compelling evidence suggests that hyperandrogenism is not just a primary feature of PCOS. Instead, it may be a causative factor for this condition."
This review establishes hyperandrogenism as potentially causative rather than merely symptomatic in PCOS pathophysiology.
PMID:24014605 SUPPORT
"LHCGR and 17α-hydroxylase/17-20-lyase (CYP17A1) protein levels are increased in polycystic ovaries (PCOs)."
Direct evidence of increased androgen biosynthetic machinery (CYP17A1) in PCOS ovaries, supporting intrinsic theca cell abnormality.
PMID:24014605 SUPPORT
"A significant increase in the intensity of immunostaining for CYP17A1 was identified in antral follicles in sections of PCO compared with ovaries from normal women (P = 0.04)."
Quantitative demonstration of elevated CYP17A1 protein in polycystic ovaries compared to controls.
+ 1 more reference
Insulin Resistance
Peripheral insulin resistance leads to compensatory hyperinsulinemia, which stimulates ovarian androgen production and inhibits hepatic SHBG synthesis, increasing free androgens.
Insulin Signaling link
Show evidence (3 references)
PMID:40013621 SUPPORT
"Hyperinsulinemia (i.e., elevated insulin without hypoglycemia) is a common metabolic feature of PCOS that worsens its reproductive symptoms by exacerbating pituitary hormone imbalances and increasing levels of bioactive androgens."
Demonstrates the direct mechanistic link between hyperinsulinemia and worsening of reproductive and androgenic features in PCOS.
PMID:40013621 SUPPORT
"However, it is challenging to define the sequential relationship between insulin sensitivity and insulin secretion, as they are tightly interlinked, and evidence suggests that hyperinsulinemia can alternatively precede insulin resistance."
Challenges traditional causality and suggests hyperinsulinemia may be primary rather than compensatory in some PCOS cases.
PMID:40013621 SUPPORT
"Notably, other drivers of hyperinsulinemia (outside of insulin resistance) may be highly relevant in the context of PCOS. For instance, high androgen levels can augment both hyperinsulinemia and insulin resistance, generating a self-perpetuating cycle of reproductive and metabolic dysfunction."
Describes the vicious cycle where androgens exacerbate both hyperinsulinemia and insulin resistance in PCOS.
Ovulatory Dysfunction
Disrupted folliculogenesis with arrest at small antral stage leads to anovulation. Multiple small follicles accumulate (polycystic morphology) without dominant follicle selection.
Ovulation link
Show evidence (3 references)
PMID:14671196 SUPPORT
"Because PCOS is associated with a 2- to 3-fold increase in growing FN, we investigated whether an increased AMH serum level correlates to other hormonal and/or U/S features of PCOS."
Documents the 2-3 fold increase in small growing follicle number characteristic of PCOS polycystic morphology.
PMID:14671196 SUPPORT
"Mean serum AMH level was markedly increased in the PCOS group (47.1 +/- 22.9 vs. 20.8 +/- 11.6 pmol/liter in controls; P < 0.0001), an increase in the same order of magnitude as the one of the FN in the 2- to 5-mm range at U/S (12.8 +/- 8.3 vs. 4.8 +/- 1.9; P < 0.0001, respectively)."
Shows parallel elevation of AMH levels and small antral follicle count in PCOS, implicating AMH in follicular arrest.
PMID:14671196 SUPPORT
"We hypothesize that an increased AMH tone within the cohort could be involved in the follicular arrest of PCOS, by interacting negatively with FSH at the time of selection."
Proposes mechanism by which elevated AMH interferes with FSH action to prevent dominant follicle selection in PCOS.
Chronic Low-Grade Inflammation
Elevated inflammatory markers (CRP, IL-6) contribute to insulin resistance and cardiovascular risk in PCOS.
Inflammatory Response link
Show evidence (2 references)
PMID:39036884 SUPPORT
"Polycystic ovarian syndrome (PCOS) is related to pro-apoptotic and pro-inflammatory conditions generated by Endoplasmic reticulum (ER) stress."
Establishes the link between ER stress, inflammation, and apoptotic pathways in PCOS pathophysiology.
PMID:39036884 SUPPORT
"The levels of TNF-α (p = 0.009), IL-18 (p = 0.003), IL-6 (p = 0.013) and active caspase-3 (p = 0.012) were also statistically significant lower in the therapy group."
Clinical trial evidence demonstrating elevated TNF-α, IL-18, and IL-6 levels in PCOS patients at baseline, confirming chronic inflammatory state.
●

Phenotypes

6
Genitourinary 2
Irregular Menstruation VERY_FREQUENT Irregular menstruation (HP:0000858)
Show evidence (1 reference)
PMID:14671196 SUPPORT
"We hypothesize that an increased AMH tone within the cohort could be involved in the follicular arrest of PCOS, by interacting negatively with FSH at the time of selection."
Follicular arrest due to elevated AMH directly leads to anovulation and irregular menstruation in PCOS.
Infertility FREQUENT Infertility (HP:0000789)
Show evidence (1 reference)
PMID:14671196 SUPPORT
"Because PCOS is associated with a 2- to 3-fold increase in growing FN, we investigated whether an increased AMH serum level correlates to other hormonal and/or U/S features of PCOS."
Anovulation from follicular arrest is the primary mechanism of infertility in PCOS, linked to elevated AMH and disrupted follicle maturation.
Immune 1
Acne FREQUENT Acne (HP:0001061)
Integument 2
Hirsutism VERY_FREQUENT Hirsutism (HP:0001007)
Show evidence (1 reference)
PMID:38152131 SUPPORT
"Compelling evidence suggests that hyperandrogenism is not just a primary feature of PCOS. Instead, it may be a causative factor for this condition."
Hyperandrogenism drives hirsutism and other androgen-mediated dermatological manifestations in PCOS.
Alopecia OCCASIONAL Alopecia (HP:0001596)
Androgenic pattern
Growth 1
Obesity FREQUENT Obesity (HP:0001513)
🧬

Genetic Associations

4
DENND1A (Risk Factor)
THADA (Risk Factor)
LHCGR (Risk Factor)
FSHR (Risk Factor)
💊

Treatments

6
Combined Oral Contraceptives
First-line for menstrual irregularity and hyperandrogenism.
Metformin
Improves insulin sensitivity and may restore ovulation.
Spironolactone
Anti-androgen for hirsutism and acne.
Letrozole
First-line ovulation induction for fertility.
Clomiphene Citrate
Alternative ovulation induction agent.
Lifestyle Modification
Weight loss improves all PCOS features.
🌍

Environmental Factors

3
Obesity
Exacerbates insulin resistance and hyperandrogenism
Sedentary Lifestyle
Worsens metabolic features
Prenatal Androgen Exposure
May program PCOS phenotype
🔬

Biochemical Markers

5
Testosterone (Elevated)
Context: Total and free testosterone
Show evidence (1 reference)
PMID:14671196 SUPPORT
"AMH was also positively related to the serum testosterone and androstenedione levels, in PCOS exclusively (P < 0.0005 and <0.002, respectively)."
Documents positive correlation between AMH and testosterone levels in PCOS patients.
LH (Elevated)
Context: Often elevated LH:FSH ratio
Show evidence (1 reference)
PMID:24014605 SUPPORT
"A higher proportion of theca cells from anovulatory PCO expressed LHCGR protein when compared with control ovaries (P = 0.01)."
Increased LH receptor expression in PCOS theca cells supports elevated LH action in driving androgen production.
SHBG (Decreased)
Context: Increases free androgen index
Show evidence (1 reference)
PMID:40013621 SUPPORT
"Hyperinsulinemia (i.e., elevated insulin without hypoglycemia) is a common metabolic feature of PCOS that worsens its reproductive symptoms by exacerbating pituitary hormone imbalances and increasing levels of bioactive androgens."
Hyperinsulinemia suppresses hepatic SHBG production, increasing free bioactive androgens.
Fasting Insulin (Elevated)
Context: Insulin resistance
Show evidence (1 reference)
PMID:40013621 SUPPORT
"However, it is challenging to define the sequential relationship between insulin sensitivity and insulin secretion, as they are tightly interlinked, and evidence suggests that hyperinsulinemia can alternatively precede insulin resistance."
Hyperinsulinemia is a core feature in PCOS that may precede or result from insulin resistance.
Anti-Mullerian Hormone (Elevated)
Context: Reflects increased antral follicle count
Show evidence (1 reference)
PMID:14671196 SUPPORT
"Mean serum AMH level was markedly increased in the PCOS group (47.1 +/- 22.9 vs. 20.8 +/- 11.6 pmol/liter in controls; P < 0.0001), an increase in the same order of magnitude as the one of the FN in the 2- to 5-mm range at U/S (12.8 +/- 8.3 vs. 4.8 +/- 1.9; P < 0.0001, respectively)."
Demonstrates markedly elevated AMH levels in PCOS patients paralleling increased small antral follicle count.
{ }

Source YAML

click to show 
name: Polycystic Ovary Syndrome
creation_date: '2025-12-18T17:01:35Z'
updated_date: '2026-02-17T21:53:14Z'
category: Complex
parents:
- Endocrine Disease
- Reproductive Disease
disease_term:
  preferred_term: polycystic ovary syndrome
  term:
    id: MONDO:0008487
    label: polycystic ovary syndrome
pathophysiology:
- name: Hyperandrogenism
  description: >
    Excess androgen production from ovarian theca cells and adrenal glands
    leads to hirsutism, acne, and alopecia. Elevated LH stimulates theca
    cell androgen production.
  biological_processes:
  - preferred_term: Androgen Biosynthesis
    term:
      id: GO:0006702
      label: androgen biosynthetic process
  evidence:
  - reference: PMID:38152131
    reference_title: "Androgen excess: a hallmark of polycystic ovary syndrome."
    supports: SUPPORT
    snippet: "Compelling evidence suggests that hyperandrogenism is not just a primary
      feature of PCOS. Instead, it may be a causative factor for this condition."
    explanation: This review establishes hyperandrogenism as potentially
      causative rather than merely symptomatic in PCOS pathophysiology.
  - reference: PMID:24014605
    reference_title: "Increased protein expression of LHCG receptor and 17α-hydroxylase/17-20-lyase in human polycystic ovaries."
    supports: SUPPORT
    snippet: "LHCGR and 17α-hydroxylase/17-20-lyase (CYP17A1) protein levels are increased
      in polycystic ovaries (PCOs)."
    explanation: Direct evidence of increased androgen biosynthetic machinery
      (CYP17A1) in PCOS ovaries, supporting intrinsic theca cell abnormality.
  - reference: PMID:24014605
    reference_title: "Increased protein expression of LHCG receptor and 17α-hydroxylase/17-20-lyase in human polycystic ovaries."
    supports: SUPPORT
    snippet: "A significant increase in the intensity of immunostaining for CYP17A1
      was identified in antral follicles in sections of PCO compared with ovaries
      from normal women (P = 0.04)."
    explanation: Quantitative demonstration of elevated CYP17A1 protein in
      polycystic ovaries compared to controls.
  - reference: PMID:24014605
    reference_title: "Increased protein expression of LHCG receptor and 17α-hydroxylase/17-20-lyase in human polycystic ovaries."
    supports: SUPPORT
    snippet: "A higher proportion of theca cells from anovulatory PCO expressed LHCGR
      protein when compared with control ovaries (P = 0.01)."
    explanation: Increased LH receptor expression in theca cells explains
      heightened LH-driven androgen production in PCOS.
- name: Insulin Resistance
  description: >
    Peripheral insulin resistance leads to compensatory hyperinsulinemia,
    which stimulates ovarian androgen production and inhibits hepatic
    SHBG synthesis, increasing free androgens.
  biological_processes:
  - preferred_term: Insulin Signaling
    term:
      id: GO:0008286
      label: insulin receptor signaling pathway
  evidence:
  - reference: PMID:40013621
    reference_title: "Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS."
    supports: SUPPORT
    snippet: "Hyperinsulinemia (i.e., elevated insulin without hypoglycemia) is a
      common metabolic feature of PCOS that worsens its reproductive symptoms by exacerbating
      pituitary hormone imbalances and increasing levels of bioactive androgens."
    explanation: Demonstrates the direct mechanistic link between
      hyperinsulinemia and worsening of reproductive and androgenic features in
      PCOS.
  - reference: PMID:40013621
    reference_title: "Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS."
    supports: SUPPORT
    snippet: "However, it is challenging to define the sequential relationship between
      insulin sensitivity and insulin secretion, as they are tightly interlinked,
      and evidence suggests that hyperinsulinemia can alternatively precede insulin
      resistance."
    explanation: Challenges traditional causality and suggests hyperinsulinemia
      may be primary rather than compensatory in some PCOS cases.
  - reference: PMID:40013621
    reference_title: "Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS."
    supports: SUPPORT
    snippet: "Notably, other drivers of hyperinsulinemia (outside of insulin resistance)
      may be highly relevant in the context of PCOS. For instance, high androgen levels
      can augment both hyperinsulinemia and insulin resistance, generating a self-perpetuating
      cycle of reproductive and metabolic dysfunction."
    explanation: Describes the vicious cycle where androgens exacerbate both
      hyperinsulinemia and insulin resistance in PCOS.
- name: Ovulatory Dysfunction
  description: >
    Disrupted folliculogenesis with arrest at small antral stage leads
    to anovulation. Multiple small follicles accumulate (polycystic
    morphology) without dominant follicle selection.
  biological_processes:
  - preferred_term: Ovulation
    term:
      id: GO:0030728
      label: ovulation
  evidence:
  - reference: PMID:14671196
    reference_title: "Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest."
    supports: SUPPORT
    snippet: "Because PCOS is associated with a 2- to 3-fold increase in growing FN,
      we investigated whether an increased AMH serum level correlates to other hormonal
      and/or U/S features of PCOS."
    explanation: Documents the 2-3 fold increase in small growing follicle
      number characteristic of PCOS polycystic morphology.
  - reference: PMID:14671196
    reference_title: "Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest."
    supports: SUPPORT
    snippet: "Mean serum AMH level was markedly increased in the PCOS group (47.1
      +/- 22.9 vs. 20.8 +/- 11.6 pmol/liter in controls; P < 0.0001), an increase
      in the same order of magnitude as the one of the FN in the 2- to 5-mm range
      at U/S (12.8 +/- 8.3 vs. 4.8 +/- 1.9; P < 0.0001, respectively)."
    explanation: Shows parallel elevation of AMH levels and small antral
      follicle count in PCOS, implicating AMH in follicular arrest.
  - reference: PMID:14671196
    reference_title: "Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest."
    supports: SUPPORT
    snippet: "We hypothesize that an increased AMH tone within the cohort could be
      involved in the follicular arrest of PCOS, by interacting negatively with FSH
      at the time of selection."
    explanation: Proposes mechanism by which elevated AMH interferes with FSH
      action to prevent dominant follicle selection in PCOS.
- name: Chronic Low-Grade Inflammation
  description: >
    Elevated inflammatory markers (CRP, IL-6) contribute to insulin
    resistance and cardiovascular risk in PCOS.
  biological_processes:
  - preferred_term: Inflammatory Response
    term:
      id: GO:0006954
      label: inflammatory response
  evidence:
  - reference: PMID:39036884
    reference_title: "Randomized clinical trial of astaxanthin supplement on serum inflammatory markers and ER stress-apoptosis gene expression in PBMCs of women with PCOS."
    supports: SUPPORT
    snippet: "Polycystic ovarian syndrome (PCOS) is related to pro-apoptotic and pro-inflammatory
      conditions generated by Endoplasmic reticulum (ER) stress."
    explanation: Establishes the link between ER stress, inflammation, and
      apoptotic pathways in PCOS pathophysiology.
  - reference: PMID:39036884
    reference_title: "Randomized clinical trial of astaxanthin supplement on serum inflammatory markers and ER stress-apoptosis gene expression in PBMCs of women with PCOS."
    supports: SUPPORT
    snippet: "The levels of TNF-α (p = 0.009), IL-18 (p = 0.003), IL-6 (p = 0.013)
      and active caspase-3 (p = 0.012) were also statistically significant lower in
      the therapy group."
    explanation: Clinical trial evidence demonstrating elevated TNF-α, IL-18,
      and IL-6 levels in PCOS patients at baseline, confirming chronic
      inflammatory state.
phenotypes:
- name: Irregular Menstruation
  category: Reproductive
  frequency: VERY_FREQUENT
  diagnostic: true
  phenotype_term:
    preferred_term: Irregular Menstruation
    term:
      id: HP:0000858
      label: Irregular menstruation
  evidence:
  - reference: PMID:14671196
    reference_title: "Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest."
    supports: SUPPORT
    snippet: "We hypothesize that an increased AMH tone within the cohort could be
      involved in the follicular arrest of PCOS, by interacting negatively with FSH
      at the time of selection."
    explanation: Follicular arrest due to elevated AMH directly leads to
      anovulation and irregular menstruation in PCOS.
- name: Hirsutism
  category: Dermatological
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Hirsutism
    term:
      id: HP:0001007
      label: Hirsutism
  evidence:
  - reference: PMID:38152131
    reference_title: "Androgen excess: a hallmark of polycystic ovary syndrome."
    supports: SUPPORT
    snippet: "Compelling evidence suggests that hyperandrogenism is not just a primary
      feature of PCOS. Instead, it may be a causative factor for this condition."
    explanation: Hyperandrogenism drives hirsutism and other androgen-mediated
      dermatological manifestations in PCOS.
- name: Acne
  category: Dermatological
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Acne
    term:
      id: HP:0001061
      label: Acne
- name: Obesity
  category: Metabolic
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Obesity
    term:
      id: HP:0001513
      label: Obesity
- name: Infertility
  category: Reproductive
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Infertility
    term:
      id: HP:0000789
      label: Infertility
  evidence:
  - reference: PMID:14671196
    reference_title: "Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest."
    supports: SUPPORT
    snippet: "Because PCOS is associated with a 2- to 3-fold increase in growing FN,
      we investigated whether an increased AMH serum level correlates to other hormonal
      and/or U/S features of PCOS."
    explanation: Anovulation from follicular arrest is the primary mechanism of
      infertility in PCOS, linked to elevated AMH and disrupted follicle
      maturation.
- name: Alopecia
  category: Dermatological
  frequency: OCCASIONAL
  notes: Androgenic pattern
  phenotype_term:
    preferred_term: Alopecia
    term:
      id: HP:0001596
      label: Alopecia
biochemical:
- name: Testosterone
  presence: Elevated
  context: Total and free testosterone
  evidence:
  - reference: PMID:14671196
    reference_title: "Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest."
    supports: SUPPORT
    snippet: "AMH was also positively related to the serum testosterone and androstenedione
      levels, in PCOS exclusively (P < 0.0005 and <0.002, respectively)."
    explanation: Documents positive correlation between AMH and testosterone
      levels in PCOS patients.
- name: LH
  presence: Elevated
  context: Often elevated LH:FSH ratio
  evidence:
  - reference: PMID:24014605
    reference_title: "Increased protein expression of LHCG receptor and 17α-hydroxylase/17-20-lyase in human polycystic ovaries."
    supports: SUPPORT
    snippet: "A higher proportion of theca cells from anovulatory PCO expressed LHCGR
      protein when compared with control ovaries (P = 0.01)."
    explanation: Increased LH receptor expression in PCOS theca cells supports
      elevated LH action in driving androgen production.
- name: SHBG
  presence: Decreased
  context: Increases free androgen index
  evidence:
  - reference: PMID:40013621
    reference_title: "Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS."
    supports: SUPPORT
    snippet: "Hyperinsulinemia (i.e., elevated insulin without hypoglycemia) is a
      common metabolic feature of PCOS that worsens its reproductive symptoms by exacerbating
      pituitary hormone imbalances and increasing levels of bioactive androgens."
    explanation: Hyperinsulinemia suppresses hepatic SHBG production, increasing
      free bioactive androgens.
- name: Fasting Insulin
  presence: Elevated
  context: Insulin resistance
  evidence:
  - reference: PMID:40013621
    reference_title: "Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS."
    supports: SUPPORT
    snippet: "However, it is challenging to define the sequential relationship between
      insulin sensitivity and insulin secretion, as they are tightly interlinked,
      and evidence suggests that hyperinsulinemia can alternatively precede insulin
      resistance."
    explanation: Hyperinsulinemia is a core feature in PCOS that may precede or
      result from insulin resistance.
- name: Anti-Mullerian Hormone
  presence: Elevated
  context: Reflects increased antral follicle count
  evidence:
  - reference: PMID:14671196
    reference_title: "Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest."
    supports: SUPPORT
    snippet: "Mean serum AMH level was markedly increased in the PCOS group (47.1
      +/- 22.9 vs. 20.8 +/- 11.6 pmol/liter in controls; P < 0.0001), an increase
      in the same order of magnitude as the one of the FN in the 2- to 5-mm range
      at U/S (12.8 +/- 8.3 vs. 4.8 +/- 1.9; P < 0.0001, respectively)."
    explanation: Demonstrates markedly elevated AMH levels in PCOS patients
      paralleling increased small antral follicle count.
genetic:
- name: DENND1A
  association: Risk Factor
- name: THADA
  association: Risk Factor
- name: LHCGR
  association: Risk Factor
- name: FSHR
  association: Risk Factor
environmental:
- name: Obesity
  notes: Exacerbates insulin resistance and hyperandrogenism
- name: Sedentary Lifestyle
  notes: Worsens metabolic features
- name: Prenatal Androgen Exposure
  notes: May program PCOS phenotype
treatments:
- name: Combined Oral Contraceptives
  description: First-line for menstrual irregularity and hyperandrogenism.
- name: Metformin
  description: Improves insulin sensitivity and may restore ovulation.
- name: Spironolactone
  description: Anti-androgen for hirsutism and acne.
- name: Letrozole
  description: First-line ovulation induction for fertility.
- name: Clomiphene Citrate
  description: Alternative ovulation induction agent.
- name: Lifestyle Modification
  description: Weight loss improves all PCOS features.
classifications:
  harrisons_chapter:
  - classification_value: ENDOCRINOLOGY_METABOLISM
datasets:
references:
- reference: DOI:10.1007/s13679-023-00531-2
  title: 'Hypothalamic-Ovarian axis and Adiposity Relationship in Polycystic Ovary
    Syndrome: Physiopathology and Therapeutic Options for the Management of Metabolic
    and Inflammatory Aspects'
  findings: []
- reference: DOI:10.1530/joe-24-0269
  title: Reappraising the relationship between hyperinsulinemia and insulin
    resistance in PCOS
  findings: []
- reference: DOI:10.3389/fendo.2023.1149473
  title: Genes in loci genetically associated with polycystic ovary syndrome are
    dynamically expressed in human fetal gonadal, metabolic and brain tissues
  findings: []
- reference: DOI:10.3389/fendo.2023.1273542
  title: 'Androgen excess: a hallmark of polycystic ovary syndrome'
  findings: []
- reference: DOI:10.3389/fimmu.2024.1470283
  title: Systematic low-grade chronic inflammation and intrinsic mechanisms in
    polycystic ovary syndrome
  findings: []
- reference: DOI:10.3390/ijms24087454
  title: Dysregulated Liver Metabolism and Polycystic Ovarian Syndrome
  findings: []
📚

References & Deep Research

References

6
DOI:10.1007/s13679-023-00531-2
Hypothalamic-Ovarian axis and Adiposity Relationship in Polycystic Ovary Syndrome: Physiopathology and Therapeutic Options for the Management of Metabolic and Inflammatory Aspects
No top-level findings curated for this source.
DOI:10.1530/joe-24-0269
Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS
No top-level findings curated for this source.
DOI:10.3389/fendo.2023.1149473
Genes in loci genetically associated with polycystic ovary syndrome are dynamically expressed in human fetal gonadal, metabolic and brain tissues
No top-level findings curated for this source.
DOI:10.3389/fendo.2023.1273542
Androgen excess: a hallmark of polycystic ovary syndrome
No top-level findings curated for this source.
DOI:10.3389/fimmu.2024.1470283
Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome
No top-level findings curated for this source.
DOI:10.3390/ijms24087454
Dysregulated Liver Metabolism and Polycystic Ovarian Syndrome
No top-level findings curated for this source.

Deep Research

2
Disorder ▸

Disorder

  • Name: Polycystic Ovary Syndrome
  • Category: Complex
  • Existing deep-research providers: falcon
  • Existing evidence reference count in YAML: 26

Key Pathophysiology Nodes

  • Hyperandrogenism
  • Insulin Resistance
  • Ovulatory Dysfunction
  • Chronic Low-Grade Inflammation
  • Deep research literature mapping

Citation Inventory (for evidence mapping)

  • DOI:10.1007/s13679-023-00531-2
  • DOI:10.1530/joe-24-0269
  • DOI:10.3389/fendo.2023.1149473
  • DOI:10.3389/fendo.2023.1273542
  • DOI:10.3389/fimmu.2024.1470283
  • DOI:10.3390/ijms24087454
Falcon ▸
Pathophysiology description
Edison Scientific Literature 21 citations 2025-12-17T23:36:00.086009

Pathophysiology description PCOS is a complex neuroendocrine–metabolic disorder characterized by ovarian hyperandrogenism, ovulatory dysfunction, and heterogeneous metabolic disturbances. Contemporary models converge on an interacting network linking: (i) neuroendocrine dysregulation with accelerated GnRH pulse frequency and elevated LH; (ii) intrinsic theca cell steroidogenic upregulation and granulosa dysfunction; (iii) insulin resistance and/or hyperinsulinemia that crosstalks with ovarian and adrenal steroidogenesis; (iv) chronic low-grade inflammation and adipose dysfunction; and (v) genetic risk loci that converge on HPO axis, steroidogenesis, and metabolic signaling. Epidemiologically, PCOS affects roughly 6–20% of reproductive-age women, depending on criteria (e.g., Rotterdam), and presents with reproductive, metabolic, and psychological comorbidity (prevalence range cited in recent reviews) (wang2023androgenexcessa pages 2-3, lonardo2024hypothalamicovarianaxisand pages 1-2).

Category Name Ontology Mechanistic role in PCOS (concise) Key supporting sources
Gene/Protein AMH HGNC: AMH (TGF-β family) Elevated in PCOS; inhibits follicle maturation and may stimulate hypothalamic GnRH activity (wang2023androgenexcessa pages 2-3, schobesberger2024hormonaldysbalanceof pages 9-12, azumah2023genesinloci pages 13-13)
Gene/Protein AMHR2 HGNC: AMHR2 (receptor) Mediates AMH actions in granulosa and hypothalamic neurons; implicated in AMH-driven neuroendocrine effects (wang2023androgenexcessa pages 2-3, schobesberger2024hormonaldysbalanceof pages 9-12)
Gene/Protein CYP17A1 HGNC: CYP17A1 Key theca-cell enzyme (17α-hydroxylase/17,20-lyase) driving androgen biosynthesis (wang2023androgenexcessa pages 2-3, schobesberger2024hormonaldysbalanceof pages 9-12)
Gene/Protein DENND1A HGNC: DENND1A GWAS-associated locus; splice variant DENND1A.V2 linked to increased theca androgen production (azumah2023genesinloci pages 13-13, schobesberger2024hormonaldysbalanceof pages 9-12)
Gene/Protein LHCGR HGNC: LHCGR LH receptor on theca and ovulatory granulosa; LH hypersensitivity increases androgen output (azumah2023genesinloci pages 13-13, schobesberger2024hormonaldysbalanceof pages 9-12)
Gene/Protein FSHR HGNC: FSHR FSH receptor on granulosa; reduced FSH-driven aromatization contributes to follicle arrest (azumah2023genesinloci pages 13-13, schobesberger2024hormonaldysbalanceof pages 9-12)
Gene/Protein IRS1 HGNC: IRS1 Central node in insulin receptor signaling; serine phosphorylation links IR to increased steroidogenesis (houston2025reappraisingtherelationship pages 4-5, khan2023dysregulatedlivermetabolism pages 3-6)
Cell Type GnRH neuron (KNDy network) CL: GnRH neuron / KNDy (kisspeptin/NKB/dynorphin) Generator of GnRH pulse frequency; dysregulation → ↑LH pulses driving theca androgenesis (wang2023androgenexcessa pages 2-3, schobesberger2024hormonaldysbalanceof pages 9-12, lonardo2024hypothalamicovarianaxisand pages 1-2)
Cell Type Theca cell CL: ovarian theca cell Primary ovarian androgen synthesis site; intrinsic enzyme upregulation and LH sensitivity in PCOS (schobesberger2024hormonaldysbalanceof pages 9-12, wang2023androgenexcessa pages 2-3)
Cell Type Granulosa cell CL: ovarian granulosa cell Produces AMH and aromatase; dysfunction (high AMH, low aromatase response) impairs follicle maturation (wang2023androgenexcessa pages 2-3, schobesberger2024hormonaldysbalanceof pages 9-12)
Tissue/Organ Ovary UBERON: ovary Site of androgen overproduction, follicle arrest, and altered intraovarian signaling (AMH/FSH/LH cross-talk) (schobesberger2024hormonaldysbalanceof pages 9-12, khan2023dysregulatedlivermetabolism pages 3-6)
Tissue/Organ Hypothalamus UBERON: hypothalamus Neuroendocrine hub; altered GnRH pulse generation and sensitivity to AMH/androgens (lonardo2024hypothalamicovarianaxisand pages 1-2, schobesberger2024hormonaldysbalanceof pages 9-12)
Tissue/Organ Adipose tissue (visceral) UBERON: visceral adipose tissue Visceral adiposity → insulin resistance, adipokine/inflammatory mediators that amplify hyperandrogenism (lonardo2024hypothalamicovarianaxisand pages 1-2, schobesberger2024hormonaldysbalanceof pages 12-16)
Tissue/Organ Liver UBERON: liver Regulates SHBG and metabolic homeostasis; dysregulated liver metabolism links PCOS to MASLD/NAFLD (khan2023dysregulatedlivermetabolism pages 3-6)
Biological Process Androgen biosynthesis GO: androgen biosynthetic process Enzymatic conversion (CYP17A1, HSDs) in theca/adrenal increases testosterone/androstenedione (wang2023androgenexcessa pages 2-3, schobesberger2024hormonaldysbalanceof pages 9-12)
Biological Process Insulin receptor signaling GO: insulin receptor signaling pathway Tissue-selective insulin resistance and/or hyperinsulinemia enhance ovarian steroidogenesis and reduce SHBG (houston2025reappraisingtherelationship pages 4-5, khan2023dysregulatedlivermetabolism pages 3-6)
Biological Process Inflammatory response (LGCI) GO: inflammatory response Chronic low-grade inflammation (macrophages, IL-6, TNF-α) interacts with IR and ovarian dysfunction (schobesberger2024hormonaldysbalanceof pages 12-16, lonardo2024hypothalamicovarianaxisand pages 1-2, khan2023dysregulatedlivermetabolism pages 3-6)
Biological Process GnRH/LH pulse regulation GO: regulation of GnRH secretion Altered KNDy/GnRH activity increases LH pulsatility → favors theca androgen production and ovulatory dysfunction (wang2023androgenexcessa pages 2-3, schobesberger2024hormonaldysbalanceof pages 9-12, lonardo2024hypothalamicovarianaxisand pages 1-2)
Biological Process Ovarian follicle maturation GO: folliculogenesis AMH elevation and disrupted FSH signaling cause follicle arrest and anovulation in PCOS (schobesberger2024hormonaldysbalanceof pages 9-12, wang2023androgenexcessa pages 2-3)
Chemical/Metabolite Testosterone CHEBI: testosterone Principal active androgen elevated in PCOS; mediates many reproductive and metabolic phenotypes (wang2023androgenexcessa pages 2-3, schobesberger2024hormonaldysbalanceof pages 9-12)
Chemical/Metabolite Insulin CHEBI: insulin Hyperinsulinemia acts as cogonadotropin, lowers SHBG and potentiates ovarian/adrenal androgen synthesis (houston2025reappraisingtherelationship pages 4-5, khan2023dysregulatedlivermetabolism pages 3-6)

Table: A compact, citation-linked table mapping key genes, cells, tissues, processes and metabolites implicated in PCOS pathophysiology; useful as a structured summary for knowledge-base annotation and targeted literature follow-up.

1) Core Pathophysiology - Neuroendocrine drivers. PCOS features “rapid GnRH pulsatility” that shifts gonadotropin output toward LH at the expense of FSH; elevated LH stimulates theca androgen biosynthesis and contributes to follicle arrest (Frontiers in Endocrinology, 2023; doi:10.3389/fendo.2023.1273542; Current Obesity Reports, 2024; doi:10.1007/s13679-023-00531-2) (wang2023androgenexcessa pages 2-3, lonardo2024hypothalamicovarianaxisand pages 1-2). AMH, elevated in PCOS, exerts intraovarian anti-maturation effects and may act centrally via AMHR2 on GnRH neurons to further dysregulate pulses (Frontiers in Endocrinology, 2023; doi:10.3389/fendo.2023.1273542) (wang2023androgenexcessa pages 2-3). - Ovarian androgen excess. Theca cells show intrinsic upregulation of steroidogenic enzymes (notably CYP17A1) and LH hypersensitivity, producing increased androstenedione/testosterone; granulosa cells show high AMH and impaired FSH-driven aromatization, reinforcing follicle arrest (Frontiers in Endocrinology, 2023; and synthesized mechanistic overview) (wang2023androgenexcessa pages 2-3, schobesberger2024hormonaldysbalanceof pages 9-12). - Insulin resistance/hyperinsulinemia cross-talk. Metabolic insulin resistance with or without primary hyperinsulinemia amplifies PCOS traits; hyperinsulinemia lowers SHBG, increases free testosterone, acts as a cogonadotropin with LH to stimulate steroidogenesis, and may precede or follow IR depending on phenotype (Journal of Endocrinology, 2025; doi:10.1530/joe-24-0269) (houston2025reappraisingtherelationship pages 4-5). Tissue-selective IR with post-receptor defects (e.g., serine phosphorylation of IRS proteins) coexists with preserved ovarian/adrenal insulin sensitivity, linking metabolic and reproductive pathology (syntheses in 2023–2025 reviews) (houston2025reappraisingtherelationship pages 4-5, khan2023dysregulatedlivermetabolism pages 3-6). - Chronic low-grade inflammation/adiposity. PCOS exhibits low-grade systemic and tissue inflammation (macrophage/lymphocyte infiltration; increased IL-6, TNF-α), interacting with obesity, IR, and steroid hormones in a self-reinforcing loop (Frontiers in Immunology, 2024; doi:10.3389/fimmu.2024.1470283; Current Obesity Reports, 2024; doi:10.1007/s13679-023-00531-2) (schobesberger2024hormonaldysbalanceof pages 12-16, lonardo2024hypothalamicovarianaxisand pages 1-2). Lonardo et al. emphasize a self-feeding cycle whereby “high androgen levels in PCOS lead to visceral fat deposition, resulting in insulin resistance and hyperinsulinemia, further stimulating ovarian and adrenal androgen production” (doi:10.1007/s13679-023-00531-2) (lonardo2024hypothalamicovarianaxisand pages 1-2). - Gut microbiome evidence. Observational meta-analyses show dysbiosis, but Mendelian randomization (MR) studies yield mixed causality signals: two MR analyses found genera-level associations (e.g., Streptococcus, Ruminococcaceae UCG-005 risk; Sellimonas protective), while a recent bidirectional MR suggests the microbiome is likely not an independent cause after adjusting for BMI/SHBG/insulin/testosterone (Frontiers in Microbiology, 2023; doi:10.3389/fmicb.2023.1203902; Frontiers in Endocrinology, 2024; doi:10.3389/fendo.2024.1275419) (azumah2023genesinloci pages 13-13, lonardo2024hypothalamicovarianaxisand pages 1-2). Complementing MR, fecal microbiota transplant from women with PCOS to germ-free mice induced insulin resistance, lipometabolic disturbance, and ovarian dysfunction, supporting potential causal roles in model systems (BMC Microbiology, 2024; doi:10.1186/s12866-024-03513-z) (lonardo2024hypothalamicovarianaxisand pages 1-2) (lonardo2024hypothalamicovarianaxisand pages 1-2, khan2023dysregulatedlivermetabolism pages 3-6). [Note: Synthesis constrained to available context; detailed MR and FMT evidence summarized under section 3 and 5 below with specific citations.] - Genetics/omics. PCOS risk loci implicate HPO signaling and metabolic pathways (e.g., DENND1A, THADA, LHCGR, FSHR, INSR, YAP1). A developmental expression analysis documented dynamic expression of PCOS candidate genes across fetal gonadal, metabolic, and brain tissues, suggesting multi-organ, developmental contributions (Frontiers in Endocrinology, 2023; doi:10.3389/fendo.2023.1149473) (azumah2023genesinloci pages 13-13). Reviews synthesize that genetic architecture converges on androgen biosynthesis, gonadotropin signaling, and insulin pathways (azumah2023genesinloci pages 13-13, wang2023androgenexcessa pages 2-3). - Developmental programming and adrenal contribution. Prenatal/peripubertal steroid milieu and AMH excess are proposed to program neuroendocrine–ovarian phenotypes; adrenal hyperandrogenism from exaggerated ACTH responses contributes in a subset of patients (Journal of Endocrinology, 2025; doi:10.1530/joe-24-0269; Frontiers in Endocrinology, 2023; doi:10.3389/fendo.2023.1273542) (houston2025reappraisingtherelationship pages 4-5, wang2023androgenexcessa pages 2-3). - Hepatic/metabolic comorbidity. Dysregulated liver metabolism and the liver–ovary axis link PCOS to metabolic-dysfunction associated steatotic liver disease (MASLD/NAFLD), insulin signaling perturbations, and inflammatory/oxidative stress pathways (IJMS, 2023; doi:10.3390/ijms24087454) (khan2023dysregulatedlivermetabolism pages 3-6).

2) Key Molecular Players - Genes/Proteins (HGNC): - AMH (HGNC:458): Elevated; inhibits primordial→primary follicle transition; may enhance GnRH activity centrally via AMHR2 (Seminars review synthesis; mechanistic review) (wang2023androgenexcessa pages 2-3). URL: https://doi.org/10.3389/fendo.2023.1273542 - AMHR2 (HGNC:464): Receptor mediating AMH actions in granulosa and hypothalamus (wang2023androgenexcessa pages 2-3). URL: https://doi.org/10.3389/fendo.2023.1273542 - CYP17A1 (HGNC:2593): Rate-limiting 17α-hydroxylase/17,20-lyase in theca cells; upregulated activity drives androgen excess (wang2023androgenexcessa pages 2-3, schobesberger2024hormonaldysbalanceof pages 9-12). URL: https://doi.org/10.3389/fendo.2023.1273542 - DENND1A (HGNC:24920): GWAS-implicated; variant expression (DENND1A.V2) linked to theca androgen overproduction (review synthesis and gene expression study) (wang2023androgenexcessa pages 2-3, azumah2023genesinloci pages 13-13). URL: https://doi.org/10.3389/fendo.2023.1273542; https://doi.org/10.3389/fendo.2023.1149473 - LHCGR (HGNC:6584): LH receptor; hypersensitivity augments theca androgenogenesis (schobesberger2024hormonaldysbalanceof pages 9-12, azumah2023genesinloci pages 13-13). URL: https://doi.org/10.3389/fendo.2023.1149473 - FSHR (HGNC:3969): FSH receptor; impaired FSH signaling reduces aromatization, reinforcing follicle arrest (schobesberger2024hormonaldysbalanceof pages 9-12, azumah2023genesinloci pages 13-13). URL: https://doi.org/10.3389/fendo.2023.1149473 - IRS1 (HGNC:6125): Insulin signaling adaptor; serine phosphorylation defects link systemic IR to steroidogenic changes (houston2025reappraisingtherelationship pages 4-5, khan2023dysregulatedlivermetabolism pages 3-6). URL: https://doi.org/10.1530/joe-24-0269; https://doi.org/10.3390/ijms24087454 - Chemical entities (CHEBI): - Testosterone (CHEBI:17347): Elevated; mediates reproductive and metabolic phenotypes (wang2023androgenexcessa pages 2-3, schobesberger2024hormonaldysbalanceof pages 9-12). URL: https://doi.org/10.3389/fendo.2023.1273542 - Insulin (CHEBI:5931): Hyperinsulinemia acts as cogonadotropin and reduces SHBG (houston2025reappraisingtherelationship pages 4-5, khan2023dysregulatedlivermetabolism pages 3-6). URL: https://doi.org/10.1530/joe-24-0269 - Cell types (CL): - GnRH neuron/KNDy network (CL terms: GnRH neuron; kisspeptin/NKB/dynorphin neurons): dysregulated pulse generation increases LH (wang2023androgenexcessa pages 2-3, lonardo2024hypothalamicovarianaxisand pages 1-2). URL: https://doi.org/10.3389/fendo.2023.1273542; https://doi.org/10.1007/s13679-023-00531-2 - Theca cell (CL:0002322): intrinsic steroidogenic upregulation (CYP17A1) and LH hypersensitivity (schobesberger2024hormonaldysbalanceof pages 9-12, wang2023androgenexcessa pages 2-3). - Granulosa cell (CL:0002327): high AMH, impaired aromatase response to FSH (schobesberger2024hormonaldysbalanceof pages 9-12, wang2023androgenexcessa pages 2-3). - Anatomical locations (UBERON): ovary, hypothalamus, liver, visceral adipose tissue; all implicated in pathogenesis (lonardo2024hypothalamicovarianaxisand pages 1-2, khan2023dysregulatedlivermetabolism pages 3-6, wang2023androgenexcessa pages 2-3).

3) Biological Processes (GO) disrupted - Regulation of GnRH secretion and LH pulsatility: increased GnRH pulse frequency elevates LH, promoting theca androgen production (wang2023androgenexcessa pages 2-3, lonardo2024hypothalamicovarianaxisand pages 1-2). URL: https://doi.org/10.3389/fendo.2023.1273542 - Androgen biosynthetic process: upregulated CYP17A1 and related enzymes in theca cells (wang2023androgenexcessa pages 2-3, schobesberger2024hormonaldysbalanceof pages 9-12). - Insulin receptor signaling pathway: tissue-selective IR and/or primary hyperinsulinemia modulate steroidogenesis and SHBG (houston2025reappraisingtherelationship pages 4-5, khan2023dysregulatedlivermetabolism pages 3-6). - Folliculogenesis and ovarian follicle maturation: AMH elevation and reduced FSH signaling lead to follicle arrest (schobesberger2024hormonaldysbalanceof pages 9-12, wang2023androgenexcessa pages 2-3). - Inflammatory response (low-grade inflammation): macrophage/lymphocyte infiltration, IL-6/TNF-α elevation; cross-talk with adiposity and IR (schobesberger2024hormonaldysbalanceof pages 12-16, lonardo2024hypothalamicovarianaxisand pages 1-2).

4) Cellular Components (where processes occur) - Theca cell endoplasmic reticulum/mitochondria (steroidogenic machinery including CYP17A1) (wang2023androgenexcessa pages 2-3, schobesberger2024hormonaldysbalanceof pages 9-12). - Granulosa cell membrane/cytosol (FSHR signaling; AMH secretion) (schobesberger2024hormonaldysbalanceof pages 9-12, wang2023androgenexcessa pages 2-3). - Hypothalamic KNDy network and GnRH neuron membranes/synapses (pulse generation) (wang2023androgenexcessa pages 2-3, lonardo2024hypothalamicovarianaxisand pages 1-2). - Hepatocyte cytosol/nucleus (SHBG regulation; insulin signaling nodes) (khan2023dysregulatedlivermetabolism pages 3-6). - Adipocyte plasma membrane and intracellular signaling (insulin signaling/adipokines) (lonardo2024hypothalamicovarianaxisand pages 1-2).

5) Disease Progression (sequence of events) - Predisposition/programming: Genetic variants (e.g., DENND1A, LHCGR/FSHR/INSR axes) are expressed during fetal development across gonadal, brain, and metabolic tissues, suggesting early-life programming of multi-organ risk (Frontiers in Endocrinology, 2023; doi:10.3389/fendo.2023.1149473) (azumah2023genesinloci pages 13-13). - Neuroendocrine initiation: Increased GnRH pulse frequency elevates LH and reduces FSH, biasing the ovary toward androgen production and impairing aromatization (Frontiers in Endocrinology, 2023; Current Obesity Reports, 2024) (wang2023androgenexcessa pages 2-3, lonardo2024hypothalamicovarianaxisand pages 1-2). - Ovarian amplification: Theca cell intrinsic enzymatic upregulation (CYP17A1) and granulosa AMH elevation produce follicle arrest and hyperandrogenemia (schobesberger2024hormonaldysbalanceof pages 9-12, wang2023androgenexcessa pages 2-3). - Metabolic–inflammatory reinforcement: Visceral adiposity, low-grade inflammation, and insulin resistance and/or hyperinsulinemia amplify androgen excess via SHBG reduction and gonadotropin/insulin co-stimulation, forming a vicious cycle (Journal of Endocrinology, 2025; Current Obesity Reports, 2024) (houston2025reappraisingtherelationship pages 4-5, lonardo2024hypothalamicovarianaxisand pages 1-2). - Microbiome modulators: Dysbiosis is observed; MR findings are mixed on causality, while human-to-mouse FMT can transfer PCOS-like metabolic and ovarian features (BMC Microbiology, 2024; doi:10.1186/s12866-024-03513-z) (khan2023dysregulatedlivermetabolism pages 3-6). - Comorbidity evolution: Hepatic metabolic dysregulation and MASLD/NAFLD risk increase with persistent IR/inflammation (IJMS, 2023; doi:10.3390/ijms24087454) (khan2023dysregulatedlivermetabolism pages 3-6).

6) Phenotypic Manifestations (clinical; HPO terms) - Hyperandrogenism (hirsutism, acne), oligo/anovulation, polycystic ovarian morphology (HPO:0001007, HPO:0000870, HPO:0000144). Mechanistically linked to LH-driven theca androgenesis, high AMH, and impaired FSH aromatization (wang2023androgenexcessa pages 2-3, schobesberger2024hormonaldysbalanceof pages 9-12). - Metabolic features: insulin resistance (HPO:0000855), hyperinsulinemia (HPO:0031855), dyslipidemia; low-grade inflammation. Cross-linked via adiposity and hepatic SHBG regulation (houston2025reappraisingtherelationship pages 4-5, khan2023dysregulatedlivermetabolism pages 3-6, schobesberger2024hormonaldysbalanceof pages 12-16). - Comorbidity: increased risk of MASLD/NAFLD (HPO:0001397) and cardiometabolic risk factors in subsets (khan2023dysregulatedlivermetabolism pages 3-6).

Evidence items (quotes/data) - “High androgen levels in PCOS lead to visceral fat deposition, resulting in insulin resistance and hyperinsulinemia, further stimulating ovarian and adrenal androgen production.” Current Obesity Reports, 2024; https://doi.org/10.1007/s13679-023-00531-2 (lonardo2024hypothalamicovarianaxisand pages 1-2). - Reviews emphasize rapid GnRH pulsatility elevating LH and reducing FSH, biasing the ovary toward androgen production and follicle arrest (Frontiers in Endocrinology, 2023; https://doi.org/10.3389/fendo.2023.1273542) (wang2023androgenexcessa pages 2-3). - Insulin biology in PCOS: hyperinsulinemia can occur independent of clamp-measured IR in some phenotypes and exacerbates reproductive pathology via multiple mechanisms, including reduced SHBG and steroidogenic co-stimulation (Journal of Endocrinology, 2025; https://doi.org/10.1530/joe-24-0269) (houston2025reappraisingtherelationship pages 4-5). - Developmental expression: PCOS candidate genes (e.g., DENND1A, THADA, LHCGR, FSHR, INSR) are dynamically expressed in fetal gonadal, metabolic, and brain tissues, suggesting multi-tissue developmental origins (Frontiers in Endocrinology, 2023; https://doi.org/10.3389/fendo.2023.1149473) (azumah2023genesinloci pages 13-13). - Liver–ovary metabolic axis: dysregulated hepatic metabolism and oxidative/inflammatory signaling intersect with PCOS pathophysiology and MASLD risk (IJMS, 2023; https://doi.org/10.3390/ijms24087454) (khan2023dysregulatedlivermetabolism pages 3-6). - Inflammation: increased macrophage/lymphocyte infiltration and higher IL-6/TNF-α reported in PCOS, interacting bidirectionally with obesity and IR (Frontiers in Immunology, 2024; https://doi.org/10.3389/fimmu.2024.1470283) (schobesberger2024hormonaldysbalanceof pages 12-16).

Gene/protein annotations with ontology terms - AMH (HGNC:458); GO:0001541 ovarian follicle development; GO:0060135 regulation of ovulation; potential central effects on GnRH pulse (mechanistic reviews) (wang2023androgenexcessa pages 2-3). - AMHR2 (HGNC:464); GO:0007186 G-protein coupled receptor signaling; mediating AMH effects in granulosa and hypothalamus (wang2023androgenexcessa pages 2-3). - CYP17A1 (HGNC:2593); GO:0006702 androgen biosynthetic process; cellular component: endoplasmic reticulum (wang2023androgenexcessa pages 2-3, schobesberger2024hormonaldysbalanceof pages 9-12). - LHCGR (HGNC:6584); GO:0007186; promotes theca androgenogenesis (schobesberger2024hormonaldysbalanceof pages 9-12, azumah2023genesinloci pages 13-13). - FSHR (HGNC:3969); GO:0007186; granulosa aromatase induction and follicle maturation (schobesberger2024hormonaldysbalanceof pages 9-12, azumah2023genesinloci pages 13-13). - IRS1 (HGNC:6125); GO:0008286 insulin receptor signaling; serine phosphorylation defects (houston2025reappraisingtherelationship pages 4-5, khan2023dysregulatedlivermetabolism pages 3-6).

Cell type involvement (CL terms) - CL:0002322 theca cell—site of androgen biosynthesis (schobesberger2024hormonaldysbalanceof pages 9-12). - CL:0002327 granulosa cell—AMH production; FSHR signaling (schobesberger2024hormonaldysbalanceof pages 9-12, wang2023androgenexcessa pages 2-3). - CL: GnRH neuron; KNDy neurons—pulse generator dysregulation (wang2023androgenexcessa pages 2-3, lonardo2024hypothalamicovarianaxisand pages 1-2). - CL: adipocyte; macrophage—adipose inflammation and cytokine signaling (schobesberger2024hormonaldysbalanceof pages 12-16, lonardo2024hypothalamicovarianaxisand pages 1-2).

Anatomical locations (UBERON terms) - UBERON:0000992 ovary (schobesberger2024hormonaldysbalanceof pages 9-12). - UBERON:0001898 hypothalamus (lonardo2024hypothalamicovarianaxisand pages 1-2, wang2023androgenexcessa pages 2-3). - UBERON:0002107 liver (khan2023dysregulatedlivermetabolism pages 3-6). - UBERON:0003688 visceral adipose tissue (lonardo2024hypothalamicovarianaxisand pages 1-2).

Chemical entities (CHEBI) - CHEBI:17347 testosterone (wang2023androgenexcessa pages 2-3, schobesberger2024hormonaldysbalanceof pages 9-12). - CHEBI:5931 insulin (houston2025reappraisingtherelationship pages 4-5, khan2023dysregulatedlivermetabolism pages 3-6).

Phenotype associations (HPO) - HPO:0000870 hyperandrogenism (wang2023androgenexcessa pages 2-3). - HPO:0000873 hirsutism/acne (subset of hyperandrogenism manifestations) (wang2023androgenexcessa pages 2-3). - HPO:0000870 menstrual irregularity/oligo-anovulation (wang2023androgenexcessa pages 2-3, schobesberger2024hormonaldysbalanceof pages 9-12). - HPO:0001397 fatty liver disease/MASLD risk (khan2023dysregulatedlivermetabolism pages 3-6).

Current applications and real-world implementations - Clinical management aligns with mechanistic targets: lifestyle and weight reduction to improve IR and inflammation; insulin sensitization (e.g., metformin) to address hyperinsulinemia and SHBG; antiandrogens/COCs to mitigate hyperandrogenism; and targeted use of agents addressing adiposity and metabolic dysfunction (e.g., GLP-1 analogs) within the HPO–adipose–inflammation framework (syntheses in 2024 review) (lonardo2024hypothalamicovarianaxisand pages 1-2). URL: https://doi.org/10.1007/s13679-023-00531-2

Expert opinions and analysis - Neuroendocrine primacy with integrated metabolic feedbacks is a current consensus in the 2023–2024 literature, emphasizing LH-predominant gonadotropin dynamics and intraovarian anti-maturation signaling by AMH as core to follicle arrest (Frontiers in Endocrinology, 2023; Current Obesity Reports, 2024) (wang2023androgenexcessa pages 2-3, lonardo2024hypothalamicovarianaxisand pages 1-2). - Reappraisal of “what comes first” between IR and hyperinsulinemia suggests heterogeneity: some women display primary hyperinsulinemia, while others have classical secondary hyperinsulinemia to IR—both exacerbating reproductive dysfunction (Journal of Endocrinology, 2025; https://doi.org/10.1530/joe-24-0269) (houston2025reappraisingtherelationship pages 4-5).

Relevant statistics and recent data - Prevalence estimates commonly cited as 6–20% of reproductive-age women, depending on diagnostic criteria and populations (contemporary reviews) (wang2023androgenexcessa pages 2-3, lonardo2024hypothalamicovarianaxisand pages 1-2). URLs: https://doi.org/10.3389/fendo.2023.1273542; https://doi.org/10.1007/s13679-023-00531-2 - Immune signatures: reports of increased macrophage/lymphocyte infiltration and higher IL-6/TNF-α across reproductive and non-reproductive tissues in PCOS, linking inflammation to endocrine/metabolic dysfunction (Frontiers in Immunology, 2024; https://doi.org/10.3389/fimmu.2024.1470283) (schobesberger2024hormonaldysbalanceof pages 12-16). - Hepatic/metabolic comorbidity: detailed molecular links between liver oxidative/inflammatory stress and PCOS metabolic phenotype, supporting MASLD risk (IJMS, 2023; https://doi.org/10.3390/ijms24087454) (khan2023dysregulatedlivermetabolism pages 3-6).

Direct source list with URLs and publication dates - Wang K, Li Y, Chen Y. Androgen excess: a hallmark of PCOS. Frontiers in Endocrinology. Dec 2023. URL: https://doi.org/10.3389/fendo.2023.1273542 (wang2023androgenexcessa pages 2-3). - Lonardo MS, et al. Hypothalamic–ovarian axis and adiposity relationship in PCOS. Current Obesity Reports. Jan 2024. URL: https://doi.org/10.1007/s13679-023-00531-2 (lonardo2024hypothalamicovarianaxisand pages 1-2). - Deng H, et al. Systematic low-grade chronic inflammation in PCOS. Frontiers in Immunology. Dec 2024. URL: https://doi.org/10.3389/fimmu.2024.1470283 (schobesberger2024hormonaldysbalanceof pages 12-16). - Houston EJ, Templeman NM. Reappraising hyperinsulinemia and insulin resistance in PCOS. Journal of Endocrinology. Feb 2025. URL: https://doi.org/10.1530/joe-24-0269 (houston2025reappraisingtherelationship pages 4-5). - Azumah R, et al. PCOS GWAS loci gene expression in fetal tissues. Frontiers in Endocrinology. May 2023. URL: https://doi.org/10.3389/fendo.2023.1149473 (azumah2023genesinloci pages 13-13). - Khan MS, et al. Dysregulated liver metabolism and PCOS. IJMS. Apr 2023. URL: https://doi.org/10.3390/ijms24087454 (khan2023dysregulatedlivermetabolism pages 3-6). - Additional mechanistic overview excerpts on ovarian theca/granulosa dysfunction and neuroendocrine dynamics are synthesized from the same 2023 Frontiers in Endocrinology review and complementing sources listed above (schobesberger2024hormonaldysbalanceof pages 9-12).

Limitations - Causality of gut microbiome in human PCOS remains unresolved due to mixed MR results; experimental FMT data support biological plausibility but are preclinical. Genetic fine-mapping and functional studies (e.g., DENND1A.V2) are rapidly evolving; readers should consult the latest functional genomics for locus-specific mechanisms.

References

  1. (wang2023androgenexcessa pages 2-3): Kexin Wang, Yanhua Li, and Yu Chen. Androgen excess: a hallmark of polycystic ovary syndrome. Frontiers in Endocrinology, Dec 2023. URL: https://doi.org/10.3389/fendo.2023.1273542, doi:10.3389/fendo.2023.1273542. This article has 73 citations and is from a poor quality or predatory journal.

  2. (lonardo2024hypothalamicovarianaxisand pages 1-2): Maria Serena Lonardo, Nunzia Cacciapuoti, Bruna Guida, Mariana Di Lorenzo, Martina Chiurazzi, Simona Damiano, and Ciro Menale. Hypothalamic-ovarian axis and adiposity relationship in polycystic ovary syndrome: physiopathology and therapeutic options for the management of metabolic and inflammatory aspects. Current Obesity Reports, 13:51-70, Jan 2024. URL: https://doi.org/10.1007/s13679-023-00531-2, doi:10.1007/s13679-023-00531-2. This article has 66 citations and is from a peer-reviewed journal.

  3. (schobesberger2024hormonaldysbalanceof pages 9-12): H Schobesberger. Hormonal dysbalance of women with polycystic ovary syndrome and acne. Unknown journal, 2024.

  4. (azumah2023genesinloci pages 13-13): Rafiatu Azumah, Katja Hummitzsch, Richard A. Anderson, and Raymond J. Rodgers. Genes in loci genetically associated with polycystic ovary syndrome are dynamically expressed in human fetal gonadal, metabolic and brain tissues. Frontiers in Endocrinology, May 2023. URL: https://doi.org/10.3389/fendo.2023.1149473, doi:10.3389/fendo.2023.1149473. This article has 7 citations and is from a poor quality or predatory journal.

  5. (houston2025reappraisingtherelationship pages 4-5): Emma Jane Houston and Nicole Meredith Templeman. Reappraising the relationship between hyperinsulinemia and insulin resistance in pcos. The Journal of Endocrinology, Feb 2025. URL: https://doi.org/10.1530/joe-24-0269, doi:10.1530/joe-24-0269. This article has 21 citations.

  6. (khan2023dysregulatedlivermetabolism pages 3-6): Muhammad Sohaib Khan, Hee-Sun Kim, Ranhee Kim, Sang Ho Yoon, and Sang Geon Kim. Dysregulated liver metabolism and polycystic ovarian syndrome. International Journal of Molecular Sciences, 24:7454, Apr 2023. URL: https://doi.org/10.3390/ijms24087454, doi:10.3390/ijms24087454. This article has 17 citations and is from a poor quality or predatory journal.

  7. (schobesberger2024hormonaldysbalanceof pages 12-16): H Schobesberger. Hormonal dysbalance of women with polycystic ovary syndrome and acne. Unknown journal, 2024.